Recent investigations are paving the way for promising possibilities in managing this neurological disorder. Focus is increasingly on disease-modifying therapies that further slow disease progression, but also regenerate injured myelin. Cutting-edge approaches include new medications affecting specific immune system mechanisms and evaluating the pr